特一药业(002728)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002728 特一药业

已收盘 05-12 15:00:00

{"stockData":{"symbol":"002728","market":"SZ","secType":"STK","nameCN":"特一药业","latestPrice":8.13,"timestamp":1747033383000,"preClose":8.08,"halted":0,"volume":6585638,"delay":0,"changeRate":0.0062,"floatShares":376000000,"shares":513000000,"eps":0.0838,"marketStatus":"已收盘","change":0.05,"latestTime":"05-12 15:00:00","open":8.08,"high":8.15,"low":8.03,"amount":53420400,"amplitude":0.0149,"askPrice":8.13,"askSize":1318,"bidPrice":8.12,"bidSize":667,"shortable":0,"etf":0,"ttmEps":0.0838,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747099800000},"marketStatusCode":5,"adr":0,"adjPreClose":8.08,"symbolType":"stock","openAndCloseTimeList":[[1747013400000,1747020600000],[1747026000000,1747033200000]],"highLimit":8.89,"lowLimit":7.27,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":512531525,"isCdr":false,"pbRate":2.3,"roa":"--","peRate":97.016706,"roe":"1.77%","epsLYR":0.04,"committee":-0.68663,"marketValue":4167000000,"turnoverRate":0.0175,"status":0,"floatMarketCap":3060000000},"requestUrl":"/m/hq/s/002728","defaultTab":"news","newsList":[{"id":"2530172722","title":"特一药业（002728）2025年一季报简析：营收净利润同比双双增长，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2530172722","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530172722?lang=zh_cn&edition=full","pubTime":"2025-04-27 06:33","pubTimestamp":1745706824,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期特一药业发布2025年一季报。截至本报告期末，公司营业总收入2.95亿元，同比上升79.29%，归母净利润3156.73万元，同比上升244.82%。本报告期特一药业三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达49.53%。持有特一药业最多的基金为兴全中证800六个月持有指数A，目前规模为10.47亿元，最新净值1.075，较上一交易日下跌0.09%，近一年上涨16.12%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042700001730.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728"],"gpt_icon":0},{"id":"2530168845","title":"图解特一药业年报：第四季度单季净利润同比减77.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530168845","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530168845?lang=zh_cn&edition=full","pubTime":"2025-04-26 01:05","pubTimestamp":1745600756,"startTime":"0","endTime":"0","summary":"证券之星消息，特一药业2024年年报显示，公司主营收入6.88亿元，同比下降35.55%；归母净利润2049.5万元，同比下降91.9%；扣非净利润1855.24万元，同比下降92.55%；其中2024年第四季度，公司单季度主营收入2.32亿元，同比下降27.87%；单季度归母净利润1448.52万元，同比下降77.61%；单季度扣非净利润1614.41万元，同比下降74.41%；负债率26.49%，投资收益373.58万元，财务费用-71.63万元，毛利率43.92%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042600000434.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728"],"gpt_icon":0},{"id":"2530415896","title":"特一药业(002728.SZ)发布一季度业绩，归母净利润3156.73万元，同比增长244.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530415896","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530415896?lang=zh_cn&edition=full","pubTime":"2025-04-25 22:43","pubTimestamp":1745592217,"startTime":"0","endTime":"0","summary":"智通财经APP讯，特一药业(002728.SZ)发布2025年一季度报告，第一季度，公司实现营业收入2.95亿元，同比增长79.29%。归属于上市公司股东的净利润3156.73万元，同比增长244.82%。归属于上市公司股东的扣除非经常性损益的净利润3170.69万元，同比增长255.28%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1285535.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002728"],"gpt_icon":0},{"id":"2517927143","title":"特一药业：自2025年一月份以来，止咳宝片在各个销售渠道有较好的恢复，目前销售正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2517927143","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517927143?lang=zh_cn&edition=full","pubTime":"2025-03-07 08:54","pubTimestamp":1741308849,"startTime":"0","endTime":"0","summary":"证券之星消息，特一药业(002728)03月06日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，一、公司往年的销售均以华南、华东为主，请问今年在其他区域是否有突破性进展。二、公司二月份止咳宝销售，预估是否已达到或超过2023年同期水平。特一药业回复：您好！感谢您对公司的关注！公司产品销售覆盖全国大部分区域，其中化学制剂药主要通过华南地区的经销商配送至全国，销售统计数据在华南。自2025年一月份以来，止咳宝片在各个销售渠道有较好的恢复，目前销售正常。谢谢！以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700007041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","002728"],"gpt_icon":0},{"id":"2517041148","title":"特一药业：努力经营提升产品知名度和市场覆盖率","url":"https://stock-news.laohu8.com/highlight/detail?id=2517041148","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517041148?lang=zh_cn&edition=full","pubTime":"2025-03-07 08:51","pubTimestamp":1741308671,"startTime":"0","endTime":"0","summary":"证券之星消息，特一药业03月06日在投资者关系平台上答复投资者关心的问题。而不是一直这样打压股价 股价上涨 配合止咳宝营销 应该会更好一点特一药业回复：您好！股票的二级市场价格的影响因素众多，作为公司管理层，我们努力把公司的经营做得更好，科学推进营销组织变革步伐，同时通过品牌建设，进一步提高止咳宝片及特一系列产品的知名度和市场覆盖率，以利于公司长期稳定健康的发展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700007018.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002728","BK0201"],"gpt_icon":0},{"id":"2516711507","title":"特一药业(002728.SZ)累计回购2.48%股份 耗资9394.18万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516711507","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516711507?lang=zh_cn&edition=full","pubTime":"2025-03-03 16:54","pubTimestamp":1740992066,"startTime":"0","endTime":"0","summary":"智通财经APP讯，特一药业(002728.SZ)公告，公司截至2025年2月28日以集中竞价交易方式购回公司股份1272.96万股，占公司目前总股本的比例为2.48%，支付的资金总额为人民币9394.18万元(不含相关交易费用)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1256916.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0201","BK0239","002728"],"gpt_icon":0},{"id":"2509739746","title":"【机构调研记录】鹏扬基金调研科德数控、特一药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2509739746","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509739746?lang=zh_cn&edition=full","pubTime":"2025-02-07 08:24","pubTimestamp":1738887852,"startTime":"0","endTime":"0","summary":"2）特一药业 个股亮点：公司生产的，销售的肝苷片临床上适用于各种急慢性肝脏疾患。鹏扬基金成立于2016年，截至目前，资产管理规模1248.26亿元，排名55/208；资产管理规模1099.85亿元，排名47/208；管理公募基金数176只，排名36/208；旗下公募基金经理25人，排名56/208。旗下最近一年表现最佳的公募基金产品为鹏扬数字经济先锋混合A，最新单位净值为0.71，近一年增长64.07%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025020700005259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0259","002728","688305","BK0201","BK0239"],"gpt_icon":0},{"id":"2505850252","title":"特一药业(002728.SZ)发预减，2024年度净利润2000万元—2500万元 下降90.13%-92.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505850252","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505850252?lang=zh_cn&edition=full","pubTime":"2025-01-24 21:41","pubTimestamp":1737726061,"startTime":"0","endTime":"0","summary":"智通财经APP讯，特一药业 发布2024年度业绩预告，预计全年归属于上市公司股东的净利润2000万元—2500万元，同比下降90.13%-92.10%。在这个过程中，为了保证变革的顺利推进，公司减少了核心产品止咳宝片的发货，导致毛利较高的止咳宝片销售收入同比降幅较大。同时，为了进一步提高特一品牌的市场知名度和美誉度，公司在减少止咳宝片产品发货的同时，加大对品牌的宣传力度，当期销售费用占比较高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1243949.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002728"],"gpt_icon":0},{"id":"2505856764","title":"特一药业：预计2024年全年每股收益盈利:0.04元至0.05元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505856764","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505856764?lang=zh_cn&edition=full","pubTime":"2025-01-24 20:02","pubTimestamp":1737720176,"startTime":"0","endTime":"0","summary":"证券之星消息，特一药业发布业绩预告，预计2024年全年每股收益盈利:0.04元至0.05元。特一药业2024年三季报显示，公司主营收入4.56亿元，同比下降38.87%；归母净利润600.98万元，同比下降96.81%；扣非净利润240.83万元，同比下降98.7%；其中2024年第三季度，公司单季度主营收入1.42亿元，同比下降31.44%；单季度归母净利润332.04万元，同比下降90.87%；单季度扣非净利润179.36万元，同比下降94.94%；负债率30.09%，投资收益189.74万元，财务费用-127.46万元，毛利率38.84%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012400047832.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0239","BK0201"],"gpt_icon":0},{"id":"2502043880","title":"特一药业（002728）1月10日主力资金净卖出3446.63万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502043880","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502043880?lang=zh_cn&edition=full","pubTime":"2025-01-10 15:31","pubTimestamp":1736494310,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2025年1月10日收盘，特一药业报收于8.67元，下跌6.67%，换手率10.17%，成交量38.11万手，成交额3.4亿元。1月10日的资金流向数据方面，主力资金净流出3446.63万元，占总成交额10.13%，游资资金净流入331.5万元，占总成交额0.97%，散户资金净流入3115.13万元，占总成交额9.15%。特一药业主营业务：中成药品、化学制剂药品、化学原料药的研发、生产和销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025011000020492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0201","BK0239"],"gpt_icon":0},{"id":"2502690020","title":"特一药业（002728）1月9日主力资金净卖出2805.22万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502690020","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502690020?lang=zh_cn&edition=full","pubTime":"2025-01-09 15:28","pubTimestamp":1736407709,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2025年1月9日收盘，特一药业报收于9.29元，下跌2.72%，换手率9.2%，成交量34.48万手，成交额3.23亿元。1月9日的资金流向数据方面，主力资金净流出2805.22万元，占总成交额8.68%，游资资金净流入66.82万元，占总成交额0.21%，散户资金净流入2738.39万元，占总成交额8.47%。特一药业主营业务：中成药品、化学制剂药品、化学原料药的研发、生产和销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025010900019359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002728","BK0201"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1747092745573,"stockEarnings":[{"period":"1week","weight":0.0252},{"period":"1month","weight":0.0869},{"period":"3month","weight":-0.0252},{"period":"6month","weight":-0.1514},{"period":"1year","weight":-0.1746},{"period":"ytd","weight":-0.0916}],"compareEarnings":[{"period":"1week","weight":0.0275},{"period":"1month","weight":0.0405},{"period":"3month","weight":0.0154},{"period":"6month","weight":-0.0204},{"period":"1year","weight":0.0681},{"period":"ytd","weight":0.0052}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"特一药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"63146人(较上一季度减少7.04%)","perCapita":"5960股","listingDate":"2014-07-31","address":"广东省江门市台山市台城长兴路9、11号","registeredCapital":"51253万元","survey":"　　特一药业集团股份有限公司的主营业务是中成药品、化学制剂药品、化学原料药的研发、生产和销售。公司的主要产品包括止咳宝片、罗红霉素胶囊、阿莫西林胶囊、血塞通分散片、铝碳酸镁咀嚼片、皮肤病血毒丸、金匮肾气片等。此外,公司生产的止咳宝片、金匮肾气片、红霉素肠溶片和依托红霉素片等27个药品被广东省科学技术厅认定为“广东省高新技术产品”。公司的特一品牌被广东省工商行政管理局认定为“广东省著名商标”,特一品牌亦被广东省医药行业协会评为“广东省中成药、中药饮片行业领军品牌”。","listedPrice":14},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"特一药业(002728)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供特一药业(002728)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"特一药业,002728,特一药业股票,特一药业股票老虎,特一药业股票老虎国际,特一药业行情,特一药业股票行情,特一药业股价,特一药业股市,特一药业股票价格,特一药业股票交易,特一药业股票购买,特一药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"特一药业(002728)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供特一药业(002728)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}